The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALNYLAM PHARMACEUTICALS INC COM 02043Q107   34,041,978 113,085 SH   SOLE   4,792 0 108,293
AVALO THERAPEUTICS INC COM NEW 05338F306   8,660,948 468,666 SH   SOLE   19,854 0 448,812
BIONTECH SE SPONSORED ADS 09075V102   70,210,878 754,550 SH   SOLE   31,971 0 722,579
GENERATE BIOMEDICINES INC COM SHS 370920100   13,912,335 824,679 SH   SOLE   42,524 0 782,155
INSMED INC COM PAR $.01 457669307   59,688,435 559,824 SH   SOLE   23,750 0 536,074
IONIS PHARMACEUTICALS INC COM 462222100   63,329,637 798,709 SH   SOLE   33,833 0 764,876
LEGEND BIOTECH CORP SPONSORED ADS 52490G102   34,411,155 1,191,522 SH   SOLE   50,484 0 1,141,038
MINERALYS THERAPEUTICS INC COM 603170101   23,169,156 858,753 SH   SOLE   35,869 0 822,884
NATERA INC COM 632307104   32,295,764 118,975 SH   SOLE   4,971 0 114,004
PROCEPT BIOROBOTICS CORP COM 74276L105   10,497,894 464,920 SH   SOLE   19,699 0 445,221
REGENERON PHARMACEUTICALS COM 75886F107   57,764,746 92,640 SH   SOLE   3,925 0 88,715
ROIVANT SCIENCES LTD SHS G76279101   68,405,473 1,932,904 SH   SOLE   82,000 0 1,850,904
ROYALTY PHARMA PLC SHS CLASS A G7709Q104   64,806,211 1,155,809 SH   SOLE   48,971 0 1,106,838
STRUCTURE THERAPEUTICS INC SPONSORED ADS 86366E106   23,939,987 446,059 SH   SOLE   18,632 0 427,427
VERA THERAPEUTICS INC CL A 92337R101   21,404,881 498,832 SH   SOLE   21,164 0 477,668